32.49
32.49 (-0.13%)
As of Mar 09, 2021
Immunitybio, Inc. [NK]
Source:
Company Overview
ImmunityBio, Inc. is a clinical-stage biotechnology company developing next-generation therapies and vaccines that complement, harness, and amplify the immune system to defeat cancers and infectious diseases.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (844) 696-5235 |
| Industry | manufacturing |
| CEO | Richard Adcock |
| Website | www.immunitybio.com |